Vimarsana
Biggest News Aggregation in the World

Page 33 - Jun Yang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jun Yang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jun Yang Today - Breaking & Trending Today

New Strategy to Boost Electrocatalytic Performance of Pd in Ethanol Oxidation - Vimarsana News

New Strategy to Boost Electrocatalytic Performance of Pd in Ethanol Oxidation

Scientists recently invented a new approach for optimizing the electrocatalytic performance of palladium (Pd) in ethanol oxidation reaction, which is the main anodic reaction of direct ethanol fuel cells (DEFCs).

Source: azom.com
Lion Announces Sponsorship of a SPAC Company, Cooperating with Two Other Parties - Vimarsana News

Lion Announces Sponsorship of a SPAC Company, Cooperating with Two Other Parties

Lion Announces Sponsorship of a SPAC Company, Cooperating with Two Other Parties News provided by Share this article Share this article HONG KONG, March 1, 2021 /PRNewswire/ -- Lion Group Holding Ltd. ("Lion" or "the Company") (NASDAQ: LGHL), operator of an all-in-one trading platform that offers a wide spectrum of products and services with a focus on Chinese investors, today announced that one of its subsidiaries, Lion Wealth Management Limited, will cooperate with Constant Epoch Technology Development Limited ("Constant Epoch), an investment and R&D company focusing on innovative technolo...

Hungry Panda drivers fight dismissal, handed down hours after protest over pay - Vimarsana News

Hungry Panda drivers fight dismissal, handed down hours after protest over pay

Jun Yang and Xiangqian Li are taking their fight to have their jobs reinstated to the Fair Work Commission, arguing they were unfairly dismissed following a protest they organised over new pay rules.

Source: abc.net.au
MethylationToActivity: a deep learning framework for epigenetic research - Vimarsana News

MethylationToActivity: a deep learning framework for epigenetic research

Xiang Chen, Ph.D., of St. Jude Computational Biology, helped discover a framework for using DNA methylation data to reveal promoter activity and gene...

VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China - Vimarsana News

VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China

Press release content from PR Newswire. The AP news staff was not involved in its creation. VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China January 7, 2021 GMT SHANGHAI, Jan. 7, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company committed to the treatment of endocrine-related diseases, introducing the world’s leading treatment methods and drugs into the China market and hoping to provide more Chinese patients quick access to the world’s most advanced and reliable treatment solutions, today annou...

Source: apnews.com